Results 31 to 40 of about 18,308 (133)
Enhancing urology theatre waste management: impact of a ‘Green Moment’ in daily surgical practice
BJU International, EarlyView.
Fintan R. Ryan +9 more
wiley +1 more source
Urothelial carcinoma: Perioperative considerations from top to bottom
CA: A Cancer Journal for Clinicians, EarlyView.Abstract Urothelial carcinoma is an aggressive entity that is associated with significant morbidity, but there have been major advances in both our understanding of and treatment options for patients with this disease. In this review, the authors focus on novel therapeutic and diagnostic approaches in the perioperative setting, with an emphasis on ...
Wesley Yip +8 more
wiley +1 more source
The contemporary management of prostate cancer
CA: A Cancer Journal for Clinicians, EarlyView.Abstract Prostate cancer is the most common cancer in two thirds of the world, with an expected doubling in both incidence and mortality in the next two decades. No strong environmental associations exist for the development of prostate cancer; therefore, lifestyle measures are unlikely to mitigate this increasing burden.
Deep Chakrabarti +11 more
wiley +1 more source
The Clinical Significance of the Subtypes of Detrusor Overactivity: A Systematic Review
Neurourology and Urodynamics, Volume 44, Issue 7, Page 1484-1490, September 2025.ABSTRACT Introduction Detrusor overactivity (DO) is the “occurrence of detrusor contraction(s) during filling cystometry” [7] and can be “phasic” or “terminal” [26]. The aim of this systematic review was to establish whether there is any clinical significance between the different subtypes of DO in terms of demographics, underlying pathophysiology ...
Manisha Teji +2 more
wiley +1 more source
BJU International, Volume 136, Issue 3, Page 473-483, September 2025.Objectives To evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO). Patients and Methods This prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary ...
Antti Viitala +9 more
wiley +1 more source
Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer
Cancer Innovation, Volume 4, Issue 4, August 2025.Urinary microbiota in Chinese bladder cancer patients reveals distinct profiles between non‐muscle‐invasive and muscle‐invasive diseases, with potential biomarkers like Peptoniphilus spp. in high‐risk MIBC, suggesting a role in cancer progression. Dysbiosis may serve as a stratification marker for bladder cancer risk. ABSTRACT Background Bladder cancer
Nannan Li +11 more
wiley +1 more source
Cancer Reports, Volume 8, Issue 8, August 2025.ABSTRACT Background Urachal carcinoma (URC) is a rare tumor of the urinary bladder, of which the histology usually resembles that of colorectal adenocarcinoma. Achievement of cure in patients with metastatic URC is difficult, and the survival rate of these patients has remained unsatisfactory despite various efforts.
Masayasu Urushibara +13 more
wiley +1 more source
Application of Immune Checkpoint Inhibitors in Cancer
MedComm, Volume 6, Issue 8, August 2025.Immune checkpoint inhibitors (ICIs) revolutionize oncology by harnessing immunity against advanced cancers. This review systematically explores ICI mechanisms, clinical applications in advanced malignancies (e.g., head and neck squamous cell carcinoma, esophageal cancer, non‐small cell lung cancer, breast cancer, hepatocellular carcinoma, and bladder ...
Zhijun Chen +10 more
wiley +1 more source
Asia-Pacific Journal of Clinical Oncology, Volume 21, Issue 4, Page 345-358, August 2025.Molecular diagnostic testing identified mCRPC patients with BRCA mutations eligible for targeted therapies. Testing success is often contingent on the quality of tissue handling and laboratory processing techniques to minimize DNA degradation and suboptimal sequencing data quality.
Arun A. Azad +4 more
wiley +1 more source
BJU International, Volume 136, Issue 2, Page 306-313, August 2025.Objective To compare the perioperative complications of the most common focal therapy (FT) modalities for prostate cancer. Patients and Methods We assessed the GeRmAn Nationwide inpatient Data (GRAND) from 2005 to 2023, provided by the Research Data Center of the Federal Bureau of Statistics. We compared perioperative outcomes of high‐intensity focused
Nikolaos Pyrgidis +9 more
wiley +1 more source